BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28423502)

  • 21. Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases.
    Zhao C; Chen X; Yang C; Zang D; Lan X; Liao S; Zhang P; Wu J; Li X; Liu N; Liao Y; Huang H; Shi X; Jiang L; Liu X; Dou QP; Wang X; Liu J
    Oncotarget; 2017 Feb; 8(8):13942-13956. PubMed ID: 28086217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteasome inhibitor b-AP15 induces enhanced proteotoxicity by inhibiting cytoprotective aggresome formation.
    Hillert EK; Brnjic S; Zhang X; Mazurkiewicz M; Saei AA; Mofers A; Selvaraju K; Zubarev R; Linder S; D'Arcy P
    Cancer Lett; 2019 Apr; 448():70-83. PubMed ID: 30768956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ritonavir, nelfinavir, saquinavir and lopinavir induce proteotoxic stress in acute myeloid leukemia cells and sensitize them for proteasome inhibitor treatment at low micromolar drug concentrations.
    Kraus M; Müller-Ide H; Rückrich T; Bader J; Overkleeft H; Driessen C
    Leuk Res; 2014 Mar; 38(3):383-92. PubMed ID: 24418752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of apoptosis via proteasome inhibition in leukemia/lymphoma cells by two potent piperidones.
    Contreras L; Calderon RI; Varela-Ramirez A; Zhang HY; Quan Y; Das U; Dimmock JR; Skouta R; Aguilera RJ
    Cell Oncol (Dordr); 2018 Dec; 41(6):623-636. PubMed ID: 30088262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of the eIF2alpha phosphorylation mechanism in response to proteasome inhibition in melanoma and breast cancer cells.
    Yerlikaya A; DoKudur H
    Mol Biol (Mosk); 2010; 44(5):859-66. PubMed ID: 21090173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment.
    Vogel RI; Pulver T; Heilmann W; Mooneyham A; Mullany S; Zhao X; Shahi M; Richter J; Klein M; Chen L; Ding R; Konecny G; Kommoss S; Winterhoff B; Ghebre R; Bazzaro M
    Oncotarget; 2016 May; 7(21):30962-76. PubMed ID: 27121063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteasome inhibition as a novel mechanism of the proapoptotic activity of γ-secretase inhibitor I in cutaneous T-cell lymphoma.
    Biskup E; Kamstrup MR; Manfé V; Gniadecki R
    Br J Dermatol; 2013 Mar; 168(3):504-12. PubMed ID: 23445313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone deacetylase 6 (HDAC6) plays a crucial role in p38MAPK-dependent induction of heme oxygenase-1 (HO-1) in response to proteasome inhibition.
    Kästle M; Woschee E; Grune T
    Free Radic Biol Med; 2012 Dec; 53(11):2092-101. PubMed ID: 23010497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor properties.
    Anchoori RK; Tan M; Tseng SH; Peng S; Soong RS; Algethami A; Foran P; Das S; Wang C; Wang TL; Liang H; Hung CF; Roden RBS
    PLoS One; 2020; 15(1):e0227727. PubMed ID: 31940398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents.
    Chen X; Yang Q; Xiao L; Tang D; Dou QP; Liu J
    Cancer Metastasis Rev; 2017 Dec; 36(4):655-668. PubMed ID: 29039082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation.
    Rosati E; Sabatini R; De Falco F; Del Papa B; Falzetti F; Di Ianni M; Cavalli L; Fettucciari K; Bartoli A; Screpanti I; Marconi P
    Int J Cancer; 2013 Apr; 132(8):1940-53. PubMed ID: 23001755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deubiquitinating enzyme inhibitor alleviates cyclin A1-mediated proteasome inhibitor tolerance in mixed-lineage leukemia.
    Ge M; Xu Q; Kang T; Li D; Wang R; Chen Z; Xie S; Wang W; Liu H
    Cancer Sci; 2021 Jun; 112(6):2287-2298. PubMed ID: 33738896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of all-trans-retinoic acid-induced proteasome activation potentiates the differentiating effect of retinoid in acute myeloid leukemia cells.
    Fang Y; Zhou X; Lin M; Ying M; Luo P; Zhu D; Lou J; Yang B; He Q
    Mol Carcinog; 2011 Jan; 50(1):24-35. PubMed ID: 20945414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hsp70B' regulation and function.
    Noonan EJ; Place RF; Giardina C; Hightower LE
    Cell Stress Chaperones; 2007; 12(3):219-29. PubMed ID: 17915554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new gold(I) complex-Au(PPh
    Li X; Huang Q; Long H; Zhang P; Su H; Liu J
    EBioMedicine; 2019 Jan; 39():159-172. PubMed ID: 30527624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia.
    Iacovelli S; Ricciardi MR; Allegretti M; Mirabilii S; Licchetta R; Bergamo P; Rinaldo C; Zeuner A; Foà R; Milella M; McCubrey JA; Martelli AM; Tafuri A
    Oncotarget; 2015 Oct; 6(31):32089-103. PubMed ID: 26392332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atomic structure of the 26S proteasome lid reveals the mechanism of deubiquitinase inhibition.
    Dambacher CM; Worden EJ; Herzik MA; Martin A; Lander GC
    Elife; 2016 Jan; 5():e13027. PubMed ID: 26744777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arsenic trioxide induces programmed cell death through stimulation of ER stress and inhibition of the ubiquitin-proteasome system in human sarcoma cells.
    Chiu HW; Tseng YC; Hsu YH; Lin YF; Foo NP; Guo HR; Wang YJ
    Cancer Lett; 2015 Jan; 356(2 Pt B):762-72. PubMed ID: 25449439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteasome inhibition correlates with intracellular bortezomib concentrations but not with antiproliferative effects after bolus treatment in myeloma cell lines.
    Dettmer S; Theile D; Schäfer J; Seckinger A; Burhenne J; Weiss J
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1091-101. PubMed ID: 27422413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and antiproteasomal activity of novel O-benzyl salicylamide-based inhibitors built from leucine and phenylalanine.
    Jorda R; Dušek J; Řezníčková E; Pauk K; Magar PP; Imramovský A; Kryštof V
    Eur J Med Chem; 2017 Jul; 135():142-158. PubMed ID: 28441582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.